Cargando…

Editorial: Experimental models of epilepsy and related comorbidities, Volume II

Detalles Bibliográficos
Autores principales:	Shaikh, Mohd Farooq, Ngadimon, Irma Wati, Chakraborti, Ayanabha, Abdullah, Jafri Malin, Russo, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080249/ https://www.ncbi.nlm.nih.gov/pubmed/37033657 http://dx.doi.org/10.3389/fphar.2023.1182958

Ejemplares similares

Editorial: Experimental Models of Epilepsy and Related Comorbidities
por: Chakraborti, Ayanabha, et al.
Publicado: (2019)

Editorial: Experimental & Clinical Epilepsy and Related Comorbidities
por: Shaikh, Mohd. Farooq, et al.
Publicado: (2020)

Editorial: Translational Epilepsy: An Experimental to Clinical Update
por: Shaikh, Mohd Farooq, et al.
Publicado: (2022)

An Interplay Between Post-Traumatic Epilepsy and Associated Cognitive Decline: A Systematic Review
por: Ngadimon, Irma Wati, et al.
Publicado: (2022)

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
por: Paudel, Yam Nath, et al.
Publicado: (2018)

The Gut-Brain-Axis on the Manifestation of Depressive Symptoms in Epilepsy: An Evidence-Driven Hypothesis
por: Shaikh, Mohd. Farooq, et al.
Publicado: (2020)

Antibiotic and shared decision-making preferences among adolescents in Malaysia
por: Ngadimon, Irma Wati, et al.
Publicado: (2015)

Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach
por: Kundap, Uday P., et al.
Publicado: (2017)

A Systematic Review on Non-mammalian Models in Epilepsy Research
por: Johan Arief, Muhammad Faiz, et al.
Publicado: (2018)

Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios
por: Sánchez-Villalobos, José Manuel, et al.
Publicado: (2022)

Editorial: MSPP 34th scientific meeting: Pharmacological perspectives on natural products in drug discovery
por: Shaikh, Mohd. Farooq, et al.
Publicado: (2022)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Ion-channels in epilepsy
por: Akyuz, Enes, et al.
Publicado: (2023)

Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
por: Miziak, Barbara, et al.
Publicado: (2022)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
por: Operto, Francesca Felicia, et al.
Publicado: (2020)

Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior
por: Umfress, Alan, et al.
Publicado: (2022)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease
por: Wong, Jia Hui, et al.
Publicado: (2021)

Next-Generation Sequencing in Korean Children With Autism Spectrum Disorder and Comorbid Epilepsy
por: Lee, Junghan, et al.
Publicado: (2020)

Editorial: Application of plant secondary metabolites to pain neuromodulation, volume II
por: Singla, Rajeev K., et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Application of computational tools to health and environmental sciences, Volume II
por: Ruiz, Patricia, et al.
Publicado: (2022)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Editorial: Streaming inflammation: From damage to healing and resilience–Volume II
por: Devchand, Pallavi R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tapvi600s610bnts69kkr082ea